Assessment of Alpha-1-Acid Glycoprotein as a new Biomarker for Hepatocellular Carcinoma

Evaluation of HCV-associated Hepatocellular Carcinoma based on Alpha-fetoprotein levels

Assessment of the Level of Soluble CD25 as a Marker for the Detection of Hepatocellular Carcinoma in Chronic Hepatitis C virus (HCV) Infected Patients

Study of the Serum Level of Annexin A5 as a Marker for Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis Patients

Assessment of Annexin A2 as A Marker for Diagnosis of Hepatocellular Carcinoma in Compensated and Decompensated Hepatitis C Virus Treated Patients

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

Evaluation of Golgi Protein-73 as a Tumor Marker in Patients with Hepatocellular Carcinoma

Assessment of Helicobacter Pylori Status and Serum Gastrin Level as Risk Factors for Hepatocellular Carcinoma in Patients with HCV-Related Liver Cirrhosis

Assessment expression of Serum Amyloid A and LncRNAAF085935 in patients with Hepatocellular Carcinoma, Hepatitis B and Hepatitis C Virus

Significance of Serum Hepatocyte Growth Factor Level in Diagnosis of Hepatocellular Carcinoma